{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:26:21Z","timestamp":1773980781926,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00403-013-1414-x","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T10:36:04Z","timestamp":1379586964000},"page":"239-245","source":"Crossref","is-referenced-by-count":29,"title":["Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome"],"prefix":"10.1007","volume":"306","author":[{"given":"H.","family":"El-Hadidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Samir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Otb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"1414_CR1","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Robert H, Eckel MD et al (2009) \u201cHarmonizing the metabolic syndrome\u201d: a joint interim statement of the international diabetes federation task force on epidemiology and prevention national Heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640\u20131645","journal-title":"Circulation"},{"key":"1414_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-07-0633","volume":"158","author":"KM Chooi","year":"2008","unstructured":"Chooi KM, Lee JS, Kim EJ et al (2008) Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 158:203\u2013207","journal-title":"Eur J Endocrinol"},{"issue":"9536","key":"1414_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","volume":"368","author":"R Corral","year":"2006","unstructured":"Corral R, Montori A, Victor M et al (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368(9536):666\u2013678","journal-title":"Lancet"},{"key":"1414_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/cyto.2002.1953","volume":"19","author":"I Flisiak","year":"2002","unstructured":"Flisiak I, Chodynicka B, Porebski P et al (2002) Association between psoriasis severity and transforming growth factor beta 1 and beta 2 in plasma and scales from psoriatic lesions. Cytokine 19:121\u2013125","journal-title":"Cytokine"},{"key":"1414_CR5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH, Smith KD, Sato S et al (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917\u2013921","journal-title":"Nature"},{"key":"1414_CR6","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","volume":"97","author":"SM Haffner","year":"2006","unstructured":"Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A\u201311A","journal-title":"Am J Cardiol"},{"key":"1414_CR7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1440-1681.2011.05557.x","volume":"39","author":"Y Jang","year":"2012","unstructured":"Jang Y, Lee HJ, Wang Y, Sweeney G (2012) Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. Clin Exp Pharmacol Physiol 39:194\u2013199","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1414_CR8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2230.2011.04265.x","volume":"37","author":"M Kamata","year":"2012","unstructured":"Kamata M, Tada Y, Tatsuta A et al (2012) Serum lipocalin-2 levels are increased in patients with psoriasis. Clin Exp Dermatol 37:296\u2013299","journal-title":"Clin Exp Dermatol"},{"key":"1414_CR9","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425\u201310432","journal-title":"J Biol Chem"},{"key":"1414_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Seminara NM, Shin DB et al (2012) Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the UK. J Inv Dermatol 132:556\u2013562","journal-title":"J Inv Dermatol"},{"key":"1414_CR11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1034\/j.1600-0625.2002.110611.x","volume":"11","author":"L Mallbris","year":"2002","unstructured":"Mallbris L, O\u2019Brien KP, Hulth\u00e9n A et al (2002) Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp Dermatol 11:584\u2013591","journal-title":"Exp Dermatol"},{"key":"1414_CR12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1468-3083.2010.03856.x","volume":"25","author":"A Mebazaa","year":"2011","unstructured":"Mebazaa A, El Asmi M, Zidi W et al (2011) Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol 25:705\u2013709","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1414_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ijo.2009.242","volume":"34","author":"JM Moreno-Navarrete","year":"2010","unstructured":"Moreno-Navarrete JM, Manco M, Ibanez J et al (2010) Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes 34:240\u2013249","journal-title":"Int J Obes"},{"key":"1414_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","volume":"305","author":"J Roman\u00ed","year":"2012","unstructured":"Roman\u00ed J, Caix\u00e0s A, Ceperuelo-Mallafr\u00e9 V et al (2012) Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. Arch Dermatol Res 305:105\u2013112","journal-title":"Arch Dermatol Res"},{"key":"1414_CR15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.jid.5700035","volume":"126","author":"SJ Seo","year":"2006","unstructured":"Seo SJ, Ahn JY, Hong CK et al (2006) Expression of neutrophil gelatinase-associated lipocalin in skin epidermis. J Inv Dermatol 126:510\u2013512","journal-title":"J Inv Dermatol"},{"key":"1414_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2008-1062746","volume":"40","author":"D Stejskal","year":"2008","unstructured":"Stejskal D, Karpisek M, Humenanska V et al (2008) Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res 40:381\u2013385","journal-title":"Horm Metab Res"},{"key":"1414_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.2007.08068.x","volume":"157","author":"W Sterry","year":"2007","unstructured":"Sterry W, Strober BE, Menter A (2007) Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 157:649\u2013655","journal-title":"Br J Dermatol"},{"key":"1414_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang Y, Lam KS, Kraegen EW et al (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53:34\u201341","journal-title":"Clin Chem"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-013-1414-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-013-1414-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-013-1414-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T12:22:57Z","timestamp":1646569377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-013-1414-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1007\/s00403-013-1414-x","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}